research use only

Ellagic acid Topoisomerase inhibitor

Cat.No.S1327

Ellagic acid (Elagostasine, Gallogen) has antiproliferative and antioxidant property.
Jump to

Quality Control

Batch: S132701 0.5MNAOH]3.82 mg/mL]false]DMSO]0.6 mg/mL]false]Water]Insoluble]false Purity: 99.64%
99.64

Solubility

In vitro
Batch:

0.5MNAOH : 3.82 mg/mL

DMSO : 0.6 mg/mL (1.98 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 302.19 Formula

C14H6O8

Storage (From the date of receipt)
CAS No. 476-66-4 Download SDF Storage of Stock Solutions

Synonyms Elagostasine, Gallogen SMILES C1=C2C3=C(C(=C1O)O)OC(=O)C4=CC(=C(C(=C43)OC2=O)O)O

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
Topo I
Topo II

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-09-19)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07182370 ACTIVE_NOT_RECRUITING
Menopause Related Conditions; Cardiovascular Risk
National Research Council, Spain
2024-01-15
NCT04011618 UNKNOWN
Metabolic Syndrome
University of Guadalajara
2019-09-17 PHASE2
NCT04958018 Completed
Muscular Injury
Appalachian State University
2021-06-16 Not Applicable
NCT04066816 COMPLETED
Colo-rectal Cancer; Colon Cancer; Diet Habit
UConn Health
2019-05-20
NCT05025189 Completed
Healthy
University of California Los Angeles|The California Table grape Commission
2020-10-05 Not Applicable
NCT03713164 COMPLETED
Healthy
University of California, Los Angeles
2018-02-22

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map